INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...

The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to insulin lispro ...

A cheaper generic version of the rapid-acting insulin Humalog has hit the market, according to a statement Wednesday by drugmaker Eli Lilly. The company announced its plans in March amid growing ...

The InPen is for use with U-100 Lilly Humalog and Novo Nordisk Novolog rapid-acting insulin and indicated for persons aged 12 years and older. Companion Medical announced the launch of the InPen ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. INDIANAPOLIS, Ind.– Indianapolis-based Eli ...

Eli Lilly and Company announced the launch of Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL [U-200]). Eli Lilly and Company announced the launch of Humalog 200 units/mL KwikPen (insulin ...

The same dose with half the liquid volume. That's the claim of a new insulin pen from Eli Lilly and Co. The Indianapolis drugmaker became the first company to get federal approval to sell pre-filled ...